{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-385355","form_type":"8-K","ticker":"APMD","cik":"0001745648","company_name":"Apnimed, Inc.","filed_at":"2026-09-08T21:10:53+00:00","discovered_at":"2026-09-08T21:12:00.489057+00:00","generated_at":"2026-09-08T21:12:07.327432+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Apnimed Q2 net income $125.9M on gains; FDA accepts AD109 NDA, PDUFA Feb 28 2027","bullets":["Net income $125.9M vs net loss $69.5M year-ago; driven by $85.4M gain on equity-method investment sale and $57.1M deposit liability reversal.","R&D expenses $9.9M, down 38% YoY ($16.0M); G&A $12.7M, up >100% from $5.4M on commercialization prep.","Cash and equivalents $172.8M at June 30, 2026; upsized IPO raised $220.8M gross (13.8M shares at $16.00).","FDA accepted NDA for AD109 (proposed name Oxnimbi) for obstructive sleep apnea; PDUFA target date Feb 28, 2027.","Closed senior secured credit facility up to $150M with HealthCare Royalty Partners; monetized Shionogi-Apnimed interest for $100M upfront."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-385355","json":"https://secwatch.observer/filing/0001193125-26-385355.json","markdown":"https://secwatch.observer/filing/0001193125-26-385355.md","text":"https://secwatch.observer/filing/0001193125-26-385355.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526385355/0001193125-26-385355-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526385355/apmd-20260908.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-08T21:12:07.327432+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}